<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Corticosteroids for preventing postherpetic neuralgia - Jiang, X - 2023 | Cochrane Library</title> <meta content="Corticosteroids for preventing postherpetic neuralgia - Jiang, X - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005582.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Corticosteroids for preventing postherpetic neuralgia - Jiang, X - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005582.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005582.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Corticosteroids for preventing postherpetic neuralgia" name="citation_title"/> <meta content="Xin Jiang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Yanbo Li" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Ning Chen" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Muke Zhou" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Li He" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="heli2003new@126.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD005582.pub5" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/12/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005582.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005582.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005582.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones [therapeutic use]; *Herpes Zoster [drug therapy]; *Neuralgia, Postherpetic [drug therapy, prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005582.pub5&amp;doi=10.1002/14651858.CD005582.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005582\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005582\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ko","ms","hr","fr","zh_HANS","zh_HANT","th","fa","id","pl","ro"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005582.pub5",title:"Corticosteroids for preventing postherpetic neuralgia",firstPublishedDate:"Dec 5, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005582.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005582.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005582.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005582.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005582.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005582.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ro&quot;,&quot;title&quot;:&quot;Sumar&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005582.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005582.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005582.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005582.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1906 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005582.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0077"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-sec-0071"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/appendices#CD005582-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/supinfo/CD005582-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/supinfo/CD005582-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Corticosteroids for preventing postherpetic neuralgia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#CD005582-cr-0004">Xin Jiang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#CD005582-cr-0005">Yanbo Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#CD005582-cr-0006">Ning Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#CD005582-cr-0007">Muke Zhou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information#CD005582-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Li He</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information/en#CD005582-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 December 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005582.pub5">https://doi.org/10.1002/14651858.CD005582.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005582-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005582-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005582-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005582-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005582-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005582-abs-0004">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD005582-abs-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005582-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005582-abs-0001" lang="en"> <section id="CD005582-sec-0001"> <h3 class="title" id="CD005582-sec-0001">Background</h3> <p>Postherpetic neuralgia (PHN) is a common, serious, painful complication of herpes zoster. Corticosteroids have anti‐inflammatory properties, and might be beneficial. This is an update of a review first published in 2008, and previously updated in 2013. </p> </section> <section id="CD005582-sec-0002"> <h3 class="title" id="CD005582-sec-0002">Objectives</h3> <p>To assess the effects (benefits and harms) of corticosteroids in preventing postherpetic neuralgia. </p> </section> <section id="CD005582-sec-0003"> <h3 class="title" id="CD005582-sec-0003">Search methods</h3> <p>We updated the searches for randomised controlled trials (RCTs) of corticosteroids for preventing postherpetic neuralgia in the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, two other databases, and two trials registers (June 2022). We also reviewed the bibliographies of identified trials, contacted authors, and approached pharmaceutical companies to identify additional published or unpublished data. </p> </section> <section id="CD005582-sec-0004"> <h3 class="title" id="CD005582-sec-0004">Selection criteria</h3> <p>We included all RCTs involving corticosteroids given by oral, intramuscular, or intravenous routes for people of all ages, with herpes zoster of all degrees of severity within seven days after onset, compared with no treatment or placebo, but not with other treatments. </p> </section> <section id="CD005582-sec-0005"> <h3 class="title" id="CD005582-sec-0005">Data collection and analysis</h3> <p>Two review authors independently identified potential articles, extracted data, assessed the risk of bias of each trial, and the certainty of the evidence. Disagreement was resolved by discussion among the co‐authors. We followed standard Cochrane methodology. </p> </section> <section id="CD005582-sec-0006"> <h3 class="title" id="CD005582-sec-0006">Main results</h3> <p>We identified five trials with a total of 787 participants that met our inclusion criteria. No new studies were identified for this update. All were randomised, double‐blind, placebo‐controlled parallel‐group studies. </p> <p>The evidence is very uncertain about the effects of corticosteroids given orally during an acute herpes zoster infection in preventing postherpetic neuralgia six months after the onset of herpes (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.45 to 1.99; 2 trials, 114 participants; very low‐certainty evidence (downgraded for serious risk of bias and very serious imprecision)). The three other trials that fulfilled our inclusion criteria were not included in the meta‐analysis because they did not provide separate information on the number of participants with PHN at six months. </p> <p>Adverse events during or within two weeks after stopping treatment were reported in all five included trials. There were no observed differences in serious (RR 1.65, 95% CI 0.51 to 5.29; 5 trials, 755 participants; very low‐certainty evidence (downgraded for serious risk of bias and very serious imprecision)), or non‐serious adverse events (RR 1.30, 95% CI 0.90 to 1.87; 5 trials, 755 participants; low‐certainty evidence (downgraded for serious risk of bias and serious imprecision)) between the corticosteroid and placebo groups. </p> <p>One of these trials was at high risk of bias because of incomplete outcome data, two were at unclear risk of bias, and the other was at low risk of bias. The review was first published in 2008; no new RCTs were identified for inclusion in subsequent updates in 2010, 2013, and 2023. </p> </section> <section id="CD005582-sec-0007"> <h3 class="title" id="CD005582-sec-0007">Authors' conclusions</h3> <p>Based on the current available evidence, we are uncertain about the effects of corticosteroids given orally during an acute herpes zoster infection on preventing postherpetic neuralgia. </p> <p>Corticosteroids given orally or intramuscularly may result in little to no difference in the risk of adverse events in people with acute herpes zoster. </p> <p>Some researchers have recommended using corticosteroids to relieve the zoster‐associated pain in the acute phase of the disease. If further research is designed to evaluate the efficacy of corticosteroids for herpes zoster, long‐term follow‐up should be included to observe their effect on the transition from acute pain to postherpetic neuralgia. Future trials should include measurements of function and quality of life, as well as updated measures of pain. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005582-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005582-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005582-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005582-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005582-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005582-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005582-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD005582-abs-0019">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005582-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005582-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD005582-abs-0020">Polski</a> </li> <li class="section-language"> <a class="" href="full/ro#CD005582-abs-0021">Română</a> </li> <li class="section-language"> <a class="" href="full/th#CD005582-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005582-abs-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005582-abs-0014">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005582-abs-0002" lang="en"> <h3>What are the effects of corticosteroids on preventing postherpetic neuralgia?</h3> <p><b>Key messages</b> </p> <p>• We do not know if corticosteroids, given by mouth during the acute phase of a herpes zoster infection (shingles) have an effect on the prevention of postherpetic neuralgia.<br/>• Corticosteroids given by mouth or by injection into the muscle tissue may result in little to no difference in the risk of adverse events in people with acute herpes zoster. </p> <p><b>What is postherpetic neuralgia?</b> </p> <p>Postherpetic neuralgia (PHN) is a painful condition that can occur after a bout of shingles in the area where the rash occurred. Postherpetic neuralgia may persist until the person dies, and has major implications for quality of life and the use of healthcare resources. Many people with postherpetic neuralgia find that treatment has little or no effect at all. Therefore, attention has turned to stopping the development of postherpetic neuralgia. Some researchers propose that if a person develops PHN, it may suggest that they have more varicella‐zoster virus present in their bloodstream than the low amounts usually found when the virus is dormant; this leads to continued inflammation. Corticosteroids exert a potent anti‐inflammatory action, which might minimise nerve damage, and thereby relieve herpes zoster pain and prevent postherpetic neuralgia. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know if corticosteroids given acutely (within one week of the onset of the rash) during a herpes zoster infection would be effective in preventing postherpetic neuralgia. We included studies that compared corticosteroids with no treatment or placebo, but not with other treatments. We also included trials that compared corticosteroids plus routine treatment with placebo plus routine treatment. </p> <p><b>What did we do?</b> </p> <p>We searched for all relevant randomised controlled trials that described the effects of corticosteroids on preventing postherpetic neuralgia after an acute herpes zoster infection. We also assessed how certain the evidence was, considering factors, such as study size and the way in which studies were conducted. We compared and summarised the results of the studies and rated our confidence in the evidence. </p> <p><b>What did we find?</b> </p> <p>We included five studies examining the effects of corticosteroids on a total of 787 participants in our analysis. The evidence is very uncertain about the effects of corticosteroids, given by mouth during the acute phase of a zoster infection, in preventing postherpetic neuralgia six months after the onset of the acute herpetic rash. Corticosteroids given orally or intramuscularly may result in little to no difference in the risk of adverse events in people with acute herpes zoster. Based on the available studies, very low‐certainty evidence neither supports nor refutes the use of corticosteroids in acute herpes zoster infection for preventing postherpetic neuralgia. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>Our confidence is very limited because the results from the studies involved a limited number of people. Some studies did not clearly report the method of randomisation, allocation concealment, or whether the lack of compliance was due to inefficacy or side effects, which could have affected the study's results. Overall, we have very little confidence in the evidence, and further studies are needed to investigate the effects of corticosteroids in preventing postherpetic neuralgia. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The evidence is up‐to‐date to 25 June 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005582-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005582-sec-0077"></div> <h3 class="title" id="CD005582-sec-0078">Implications for practice</h3> <section id="CD005582-sec-0078"> <p>Based on the current available evidence, we are uncertain about the effects of corticosteroids given orally, during an acute herpes zoster infection, on preventing postherpetic neuralgia. Corticosteroids given orally or intramuscularly may result in little to no difference in the risk of adverse events in people with acute herpes zoster. </p> </section> <h3 class="title" id="CD005582-sec-0079">Implications for research</h3> <section id="CD005582-sec-0079"> <p>Large trials with sufficient power to detect a meaningful difference, and which include validated and approved pain outcomes have not been performed. High‐quality studies to assess the effects of corticosteroids on both short‐term pain and longer‐term postherpetic neuralgia are required. This may provide information about the mechanisms of transition from acute pain to long‐term postherpetic neuralgia. Randomised studies are also needed to definitively affirm or rule out a clinically useful role of corticosteroids in treating acute pain and pain associated with postherpetic neuralgia. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005582-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005582-sec-0008"></div> <div class="table" id="CD005582-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute herpes zoster (within 7 days of onset of rash)<br/><b>Settings:</b> hospitals and clinics<br/><b>Intervention:</b> corticosteroids </p> <p><b>Comparison:</b> placebo or routine treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo or routine treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corticosteroids</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Presence of PHN 6 months after the onset of acute herpetic rash</b><br/>Clinical manifestation<br/><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>193 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b><br/>(87 to 384) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.95</b> <br/>(0.45 to 1.99) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b><br/>Clinical manifestation and laboratory examination </p> <p><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>13 per 1000</b><br/>(3 to 42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.51 to 5.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b><br/>Clinical manifestation and laboratory examination </p> <p><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>113 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b><br/>(102 to 211) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b> <br/>(0.90 to 1.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>PHN:</b> postherpetic neuralgia; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level for serious risk of bias and 2 levels for very serious imprecision, due to the low number of events and participants and very wide CI.<br/><sup>b</sup>Downgraded 1 level for serious risk of bias and 2 levels for very serious imprecision, due to the low number of events and very wide CI.<br/><sup>c</sup>Downgraded 1 level for serious risk of bias and 1 level for serious imprecision, due to very wide CI. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005582-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005582-sec-0009"></div> <p>This is an updated version of the Cochrane review last published in 2013 (<a href="./references#CD005582-bbs2-0106" title="HanY , ZhangJ , ChenN , HeL , ZhouM , ZhuC . Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582.pub4] [PMID: 23543541]">Han 2013</a>). </p> <section id="CD005582-sec-0010"> <h3 class="title" id="CD005582-sec-0010">Description of the condition</h3> <p>Postherpetic neuralgia (PHN) is a painful condition that occurs in people following an acute herpes zoster infection (commonly referred to as shingles). Shingles is an acute vesicular eruption involving one or two adjacent dermatomes (defined as an area of skin in which sensory nerves derive from a single spinal nerve root, which lies between adjacent vertebrae), with pain often preceding the eruption by days to weeks. Herpes zoster and PHN result from reactivation of the varicella‐zoster virus (VZV) acquired during chickenpox, the primary varicella infection (<a href="./references#CD005582-bbs2-0061" title="GanEY , TianEA , TeyHL . Management of herpes zoster and post-herpetic neuralgia. American Journal of Clinical Dermatology2013;14(2):77-85. [PMID: 23456596]">Gan 2013</a>; <a href="./references#CD005582-bbs2-0071" title="KostRG , StrausSE . Postherpetic neuralgia - pathogenesis, treatment, and prevention. New England Journal of Medicine1996;335(1):32-42.">Kost 1996</a>; <a href="./references#CD005582-bbs2-0088" title="SaguilA , KaneS , MercadoM , LautersR . Herpes zoster and postherpetic neuralgia: prevention and management. American Family Physician2017;96(10):656-63. [PMID: 29431387]">Saguil 2017</a>; <a href="./references#CD005582-bbs2-0089" title="SchmaderK . Herpes zoster. Annals of Internal Medicine2018;169(3):ITC19-31. [PMID: 30083718]">Schmader 2018</a>; <a href="./references#CD005582-bbs2-0094" title="StankusSJ , DlugopolskiM , PackerD . Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician2000;61(8):2437-44; 2447-8.">Stankus 2000</a>; <a href="./references#CD005582-bbs2-0096" title="ThompsonRR , KongCL , PorcoTC , KimE , EbertCD , AcharyaNR . Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clinical Infectious Diseases2021;73(9):e3210-7. [PMID: 32829399]">Thompson 2021</a>). Reactivation of latent VZV from dorsal root ganglia is responsible for the classic dermatomal rash and pain that occurs with herpes zoster (<a href="./references#CD005582-bbs2-0053" title="AsadaH . VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: the SHEZ study. Vaccine2019;37(44):6776-81. [PMID: 31543415]">Asada 2019</a>; <a href="./references#CD005582-bbs2-0063" title="HarbeckeR , CohenJI , OxmanMN . Herpes zoster vaccines. Journal of Infectious Diseases2021;224(12 Suppl 2):S429-42. [PMID: 34590136]">Harbecke 2021</a>; <a href="./references#CD005582-bbs2-0071" title="KostRG , StrausSE . Postherpetic neuralgia - pathogenesis, treatment, and prevention. New England Journal of Medicine1996;335(1):32-42.">Kost 1996</a>). </p> <p>Unlike varicella (chickenpox), herpes zoster is a sporadic disease with an estimated lifetime incidence of 10% to 20%. The incidence of herpes zoster increases sharply with advancing age, roughly doubling in each decade past the age of 50 years. Herpes zoster is uncommon in people younger than 15 years old (<a href="./references#CD005582-bbs2-0073" title="LeP , RothbergM . Herpes zoster infection. BMJ (Clinical Research Ed)2019;364:k5095. [PMID: 30630827]">Le 2019</a>; <a href="./references#CD005582-bbs2-0094" title="StankusSJ , DlugopolskiM , PackerD . Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician2000;61(8):2437-44; 2447-8.">Stankus 2000</a>). Previous studies have reported that people older than 55 years of age accounted for more than 30% of herpes zoster cases, while children younger than 14 years old represented only 5% of herpes zoster cases (<a href="./references#CD005582-bbs2-0058" title="DonahueJG , ChooPW , MansonJE , PlattR . The incidence of herpes zoster. Archives of Internal Medicine1995;155(15):1605-9. [PMID: 7618983]">Donahue 1995</a>). The normal age‐related decrease in cell‐mediated immunity is thought to account for the increased incidence of VZV reactivation (<a href="./references#CD005582-bbs2-0094" title="StankusSJ , DlugopolskiM , PackerD . Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician2000;61(8):2437-44; 2447-8.">Stankus 2000</a>). People with disease states that affect cell‐mediated immunity, such as HIV infection and certain malignancies, are at increased risk. Chronic corticosteroid use, chemotherapy, and radiation therapy may increase the risk of developing herpes zoster (<a href="./references#CD005582-bbs2-0060" title="FilletAM . Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs &amp; Aging2002;19(5):343-54.">Fillet 2002</a>; <a href="./references#CD005582-bbs2-0068" title="KawaiK , YawnBP . Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clinic Proceedings2017;92(12):1806-21. [PMID: 29202939]">Kawai 2017</a>; <a href="./references#CD005582-bbs2-0081" title="McKaySL , GuoA , PergamSA , DoolingK . Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clinical Infectious Diseases2020;71(7):e125-34. [PMID: 31677266]">McKay 2020</a>; <a href="./references#CD005582-bbs2-0102" title="YamadaK , MoriY , CuiR , KubotaY , AsadaH , OkunoY , et al. Predictors of herpes zoster severity and immune responses according to pain trajectories: a community-based prospective cohort study. Journal of Dermatology2023;50(8):1020-33. [PMID: 37208823]">Yamada 2023</a>). Ethnic background may influence susceptibility to herpes zoster. Black people are one fourth less likely than white people to develop it. Although herpes zoster is not as contagious as primary varicella infection, people with reactivated infection can transmit VZV to non‐immune contacts. There is no seasonal incidence; the areas affected tend to be on the chest and abdomen, and the area controlled by the ophthalmic division of the trigeminal nerve. </p> <p>PHN is one of the most common complications of herpes zoster. About 20% of people with herpes zoster develop PHN (<a href="./references#CD005582-bbs2-0055" title="ChawkiS , VilcuAM , EtienneC , FinetF , BlanchonT , SoutyC , et al. Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: a register-based population study. Journal of Infection2022;84(4):531-6. [PMID: 35016899]">Chawki 2022</a>). Age is the most common risk factor, with PHN occurring nearly 15 times more frequently in people older than 50 years; the incidence of PHN after an outbreak of shingles is 10% in people over 40 years and 20% to 50% in people over 60 years (<a href="./references#CD005582-bbs2-0062" title="GriffinMJ , ChambersFA , MacSullivanR . Post herpetic neuralgia: a review. Irish Journal of Medical Science1998;167(2):74-8.">Griffin 1998</a>; <a href="./references#CD005582-bbs2-0087" title="RoslerA , SchnorpfeilF , FritzC . Treatment of postherpetic neuralgia. New England Journal of Medicine1996;335(23):1769.">Rosler 1996</a>; <a href="./references#CD005582-bbs2-0091" title="ShiraneR , TangH , HayashiK , OkunoY , IsoH , AsadaH , et al. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study. Journal of Medical Virology2017;89(2):313-7. [PMID: 27420414]">Shirane 2017</a>; <a href="./references#CD005582-bbs2-0095" title="SunX , WeiZ , LinH , JitM , LiZ , FuC . Incidence and disease burden of herpes zoster in the population aged ≥ 50 years in China: data from an integrated health care network. Journal of Infection2021;82(2):253-60. [PMID: 33359014]">Sun 2021</a>). Other possible risk factors for the development of PHN are ophthalmic zoster, a history of prodromal (defined as relating to the period between the appearance of initial symptoms and the full development of a rash or fever) pain before the appearance of skin lesions, and an immunocompromised state (<a href="./references#CD005582-bbs2-0056" title="ChooPW , GalilK , DonahueJG , WalkerAM , SpiegelmanD , PlattR . Risk factors for postherpetic neuralgia. Archives of Internal Medicine1997;157(11):1217-24. [PMID: 9183233]">Choo 1997</a>; <a href="./references#CD005582-bbs2-0094" title="StankusSJ , DlugopolskiM , PackerD . Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician2000;61(8):2437-44; 2447-8.">Stankus 2000</a>). PHN may persist until death, and has major implications for quality of life and use of healthcare resources. Although PHN has been defined in different ways, previous data support the distinction between acute (within 30 days of rash onset), subacute (30 to 120 days after rash onset), and PHN (defined as pain lasting at least 120 days from rash onset (<a href="./references#CD005582-bbs2-0059" title="DworkinRH , PortenoyRK . Proposed classification of herpes zoster pain. Lancet1994;343(8913):1648.">Dworkin 1994</a>)). There is a tendency for PHN to improve with time, and as few as 3% of people are left with severe PHN after one year. However, some series report that as many as 40% of people with PHN will continue to have long‐term problems because of incomplete or no pain relief from treatments. There is no way to predict who will recover (<a href="./references#CD005582-bbs2-0057" title="De MoragasJM , KierlandRR . The outcome of patients with herpes zoster. AMA Archives of Dermatology1957;75(2):193-6. [PMID: 13393787]">De Moragas 1957</a>). </p> </section> <section id="CD005582-sec-0011"> <h3 class="title" id="CD005582-sec-0011">Description of the intervention</h3> <p>Although the intensity of PHN typically decreases over time, pain lasts more than one year in more than 30% of people with shingles (<a href="./references#CD005582-bbs2-0067" title="KawaiK , GebremeskelBG , AcostaCJ . Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open2014;4:e004833. [PMID: 24916088]">Kawai 2014</a>). Given the complexity of the underlying pathophysiological mechanisms that contribute to the development of PHN, various strategies to prevent PHN have been proposed, including corticosteroids, antidepressants and anticonvulsants, antiviral agents, and vaccination (<a href="./references#CD005582-bbs2-0069" title="KimHJ , AhnHS , LeeJY , ChoiSS , CheongYS , KwonK , et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean Journal of Pain2017;30(1):3-17. [PMID: 28119767]">Kim 2017</a>). With insufficient good quality evidence, there are no recommended first‐line strategies for the treatment of PHN, except among a limited and well‐selected population. </p> <p>Corticosteroids (glucocorticoids, steroids) include steroid hormones that are naturally produced in the adrenal cortex of vertebrates and their synthetic analogues. Synthetic derivatives of natural steroids include prednisone, prednisolone, methylprednisolone, betamethasone, dexamethasone, triamcinolone, and hydrocortisone. Corticosteroids are involved in many physiological processes, including stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behaviour. In addition, corticosteroids are important components in the treatment of many inflammatory, allergic, immunologic, and malignant disorders, which can be administered by inhalation, orally, or intravenously (<a href="./references#CD005582-bbs2-0086" title="RhenT , CidlowskiJA . Antiinflammatory action of glucocorticoids − new mechanisms for old drugs. New England Journal of Medicine2005;353(16):1711-23. [PMID: 16236742]">Rhen 2005</a>). </p> </section> <section id="CD005582-sec-0012"> <h3 class="title" id="CD005582-sec-0012">How the intervention might work</h3> <p>VZV is a highly contagious DNA virus. It is thought that the varicella virus passes to the dorsal root ganglion via the skin during the initial infection (chicken pox) and lies dormant. The treatment of PHN is quite disappointing, and efforts have turned to approaches that may prevent the development of PHN. The pathologic studies of PHN have demonstrated damage to the sensory nerves, sensory dorsal root ganglia, and dorsal horns of the spinal cord; further pathological analysis revealed diffuse and focal infiltration of chronic inflammatory cells (<a href="./references#CD005582-bbs2-0080" title="MahalingamR , WellishM , LedererD , ForghaniB , CohrsR , GildenDH . Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. Journal of Virology1993;67(4):2381-4.">Mahalingam 1993</a>; <a href="./references#CD005582-bbs2-0083" title="PatilA , GoldustM , WollinaU . Herpes zoster: a review of clinical manifestations and management. Viruses2022;14(2):192. [PMID: 35215786]">Patil 2022</a>; <a href="./references#CD005582-bbs2-0093" title="SmithFP . Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surgical Neurology1978;10(1):50-3.">Smith 1978</a>). The presence of PHN may reflect the persistence of higher amounts of VZV than are usually found during latency, with continued inflammation. Corticosteroids exert a potent anti‐inflammatory action, which might minimise nerve damage, and thereby, relieve HZ pain and prevent PHN. On the one hand, corticosteroids effectively reduce the release of neurogenic inflammatory factors, such as substance P and calcitonin gene‐related peptide; on the other hand, they could also effectively break the vicious cycle that leads to local tissue damage and inflammation. High‐dose oral corticosteroids have been shown to produce a modest reduction in acute pain, though no effect on the incidence of PHN has been demonstrated (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0100" title="WoodMJ . Current experience with antiviral therapy for acute herpes zoster. Annals of Neurology1994;35(Suppl 1):S65-8. [PMID: 7514385]">Wood 1994</a>). </p> <p>Some older studies designed to evaluate the effectiveness of corticosteroids, such as prednisolone, triamcinolone, or prednisone therapy in preventing PHN suggested decreased pain at three and 12 months, while other studies demonstrated no benefit (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0019" title="KeczkesK , BasheerAM . Do corticosteroids prevent post-herpetic neuralgia?British Journal of Dermatology1980;102(5):551-5. [PMID: 7387900]">Keczkes 1980</a>; <a href="./references#CD005582-bbs2-0072" title="LancasterT , SilagyC , GrayS . Primary care management of acute herpes zoster: systematic review of evidence from randomised controlled trials. British Journal of General Practice1995;45(390):39-45.">Lancaster 1995</a>; <a href="./references#CD005582-bbs2-0097" title="VolminkJ , LancasterT , GrayS , SilagyC . Treatments for postherpetic neuralgia − a systematic review of randomised controlled trials. Family Practice1996;13(1):84-91.">Volmink 1996</a>). Another two large randomised, placebo‐controlled trials evaluated the combination of corticosteroids and the antiviral agent, aciclovir. One found that the addition of prednisone reduced the incidence and severity of acute pain, but provided no additional benefit for long‐term pain over aciclovir alone (<a href="./references#CD005582-bbs2-0100" title="WoodMJ . Current experience with antiviral therapy for acute herpes zoster. Annals of Neurology1994;35(Suppl 1):S65-8. [PMID: 7514385]">Wood 1994</a>). The other found that aciclovir and a corticosteroid did not significantly alter the course of long‐term zoster‐associated pain, but might improve quality of life (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>). Despite the lack of clear evidence, corticosteroids are commonly used in the treatment of herpes zoster. </p> </section> <section id="CD005582-sec-0013"> <h3 class="title" id="CD005582-sec-0013">Why it is important to do this review</h3> <p>There have been a number of trials and reviews to assess the effects of corticosteroids for preventing PHN; however, their results have been inconsistent, and we still have no clear evidence. We published the first version of this systematic review of corticosteroids for preventing PHN to evaluate the evidence and synthesise available trial data. This Cochrane review is an update of the 2013 version (<a href="./references#CD005582-bbs2-0106" title="HanY , ZhangJ , ChenN , HeL , ZhouM , ZhuC . Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582.pub4] [PMID: 23543541]">Han 2013</a>). Our last review showed moderate‐certainty evidence that did not support the use of corticosteroids in acute herpes zoster infection for preventing PHN. Therefore, we undertook this update of the review to identify whether there were new randomised controlled trials that evaluated the effectiveness of corticosteroids in preventing PHN. We also revised the reporting of the review and supplemented the methods section to meet current Cochrane standards (<a href="./references#CD005582-bbs2-0065" title="HigginsJPT , LassersonT , ThomasJ , FlemyngE , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews (MECIR). Cochrane: London, Version August 2023. Available from community.cochrane.org/mecir-manual.">Higgins 2023a</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005582-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005582-sec-0014"></div> <p>To assess the effects (benefits and harms) of corticosteroids in preventing postherpetic neuralgia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005582-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005582-sec-0015"></div> <section id="CD005582-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005582-sec-0017"> <h4 class="title">Types of studies</h4> <p>We searched for all randomised controlled trials (RCTs) of corticosteroids for preventing postherpetic neuralgia (PHN) after an acute herpes zoster infection, regardless of language or publication status. We excluded quasi‐RCTs (trials in which a partly systematic method of randomisation, such as alternation or hospital number was used). </p> <p>Cluster‐randomised and cross‐over trials were not eligible for the review. Cross‐over trials were not appropriate, as there was no possibility to return to the baseline situation after the first intervention, and the medical condition evolved over time. </p> </section> <section id="CD005582-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included people of all ages with herpes zoster of all degrees of severity, within seven days after the onset. </p> <p>We included trials in which participants received different treatments only if the trial also included people treated with corticosteroids. If a trial included a proportion of participants not eligible for inclusion in this review, we would have included it only if the data for eligible participants were reported separately. </p> </section> <section id="CD005582-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We searched for all kinds of corticosteroids, including hydrocortisone, prednisone, prednisolone, triamcinolone, and dexamethasone given by oral, intramuscular, or intravenous routes during the acute stage (starting within one week of the onset of the rash). </p> <p>We included trials that compared corticosteroids with no treatment or placebo, but not with other treatments. We also included trials that compared corticosteroids plus routine treatment with placebo plus routine treatment. </p> <p>We did not include other forms of administration of corticosteroids, such as epidural injection or topical administration, as the focus of the review was the role of systemic corticosteroids for PHN. </p> </section> <section id="CD005582-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We did not use the outcomes selected for the review as a basis for including or excluding studies. We excluded studies with less than one‐month follow‐up. </p> <section id="CD005582-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome measure was the presence of PHN six months after the onset of the acute herpetic rash. PHN was defined according to clinical diagnostic criteria as pain persisting, or recurring, at the site of shingles at least one month after the onset of the acute rash (<a href="./references#CD005582-bbs2-0079" title="MacDonaldBK , CockerellOC , SanderJW , ShorvonSD . The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain2000;123(Pt 4):665-76.">MacDonald 2000</a>). </p> </section> <section id="CD005582-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005582-list-0001"> <li> <p>Pain severity, measured by a validated visual analogue scale (VAS) or numerical descriptive scale, after three, six, and 12 months </p> </li> <li> <p>Quality of life, measured with the Short Form‐36 Health Survey questionnaire (SF‐36), after six months (<a href="./references#CD005582-bbs2-0099" title="WareJE , GandekB . Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology1998;51(11):903-12.">Ware 1998</a>) </p> </li> <li> <p>Adverse events during or within two weeks after stopping treatment. Adverse events were categorised as serious or not serious. Serious adverse events were those that were life‐threatening, required or prolonged hospitalisation, or caused death. </p> </li> </ol> </p> </section> </section> </section> <section id="CD005582-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all relevant randomised controlled trials (RCTs), without any language or publication restrictions. </p> <section id="CD005582-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases.</p> <p> <ol id="CD005582-list-0002"> <li> <p>Cochrane Neuromuscular Specialised Register (25 June 2022; <a href="./appendices#CD005582-sec-0084">Appendix 1</a>) </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 6) in the Cochrane Library (searched 25 June 2022; <a href="./appendices#CD005582-sec-0085">Appendix 2</a>) </p> </li> <li> <p>MEDLINE Ovid (January 1966 to June 2022; <a href="./appendices#CD005582-sec-0086">Appendix 3</a>); we combined this search with the Cochrane highly sensitive search strategy (<a href="./references#CD005582-bbs2-0074" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated September 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Lefebvre 2022</a>) </p> </li> <li> <p>Embase Ovid (January 1980 to June 2022; <a href="./appendices#CD005582-sec-0087">Appendix 4</a>) </p> </li> <li> <p>Chinese Biomedical Retrieval System (January 1978 to June 2022; <a href="./appendices#CD005582-sec-0088">Appendix 5</a>) </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; January 1982 to June 2022; <a href="./appendices#CD005582-sec-0089">Appendix 6</a>) </p> </li> <li> <p>ClinicalTrials.gov (searched 25 June 2022; <a href="./appendices#CD005582-sec-0090">Appendix 7</a>) </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP; searched 25 June 2022; <a href="./appendices#CD005582-sec-0091">Appendix 8</a>) </p> </li> </ol> </p> </section> <section id="CD005582-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the references of published studies to identify additional trials. We reviewed the bibliographies of the trials identified, contacted the study authors and known experts in the field, and approached pharmaceutical companies to identify additional published or unpublished data. We also examined any relevant retraction statements and errata. </p> </section> </section> <section id="CD005582-sec-0026"> <h3 class="title" id="CD005582-sec-0026">Data collection and analysis</h3> <section id="CD005582-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (X Jiang, Y Li) scrutinised the titles and abstracts identified by the searches. The review authors obtained the full text of all potentially relevant reports for independent assessment. Three review authors scrutinised all possible published and unpublished trials for inclusion. Where studies had multiple publications, we collated the reports of the same study so that each study, rather than each report, was the unit of interest for the review. In this review, we did not find multiple reports for the included studies. Publications in languages that could not be read by the authors were fully translated by a professional translator. We resolved any disagreement by discussion. We recorded the study selection process in a PRISMA flow chart (<a href="./references#CD005582-bbs2-0076" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , Gøtzsche, IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100] [PMID: 19621070]">Liberati 2009</a>). </p> </section> <section id="CD005582-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (X Jiang, N Chen) independently extracted the methodological details and data from publications, using a data extraction form. They extracted details and data on participants, methods, interventions, outcomes, and results. One author (X Jiang) entered the data into Review Manager (<a href="./references#CD005582-bbs2-0084" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Cochrane, 2020.">Review Manager 2020</a>), and a second (Y Li) checked the data entry. We obtained missing data from the study authors whenever possible. We resolved disagreements by discussion. </p> <p>For dichotomous outcomes, we extracted the number of events and the number of total participants in each group. For continuous data, we extracted means and standard deviations for each intervention group. When detailed data were not available, the inverse variance method was used if odds ratios and their confidence intervals were presented. For studies requiring translation, we extracted data from a translation of the study and checked numerical data against the study if possible. When numerical data were only presented in graphs, we requested the data from the study investigators. We considered using software for extracting numerical data from graphs when the data were not available elsewhere. </p> </section> <section id="CD005582-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (X Jiang, M Zhou) independently assessed the risk of bias using the Cochrane RoB 1 tool in each trial. They classified each domain as low, unclear, or high risk of bias, as described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005582-bbs2-0064" title="HigginsJPT , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). The risk of bias assessments took into account security of randomisation, allocation concealment, blinding, completeness of outcome data, selective outcome reporting, and any other potential sources of bias. These items were independently assessed by two review authors. We used unclear risk of bias if there were insufficient details to assess the risk of bias, or information was available, but the risk of bias was unclear. We resolved any disagreement by discussion, with reference to a third review author (L He) if necessary. We used the overall risk of bias judgements in the GRADE approach and summary of finding tables. We considered studies at high risk of bias when any domain was assessed at high risk of bias; at unclear risk of bias if insufficient information was available with which to judge; and at low risk of bias only when all individual domains were assessed at low risk of bias. </p> </section> <section id="CD005582-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed the data using Review Manager software. For dichotomous outcomes, we expressed the results as risk ratios (RRs); for continuous outcomes, we compared the means and calculated mean differences (MDs), all with 95% confidence intervals (CIs). If a study used a Cox regression model for analysis, we used the Review Manager generic inverse variance feature to permit inclusion of the data in the analysis. </p> </section> <section id="CD005582-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We did not include cross‐over studies or cluster‐RCTs. To avoid unit‐of‐analysis errors resulting from combining results of more than one time point for each study in a standard meta‐analysis, we evaluated outcomes based on the period of follow‐up (six months after disease onset). For studies that compared more than two intervention groups, we planned to select the relevant pair of intervention groups to include in the analyses. In studies with multiple intervention groups, we planned to combine groups if reasonable (e.g. study arms with different types of steroids). If it was not reasonable to combine the groups, we planned to split the 'shared' comparator group to avoid double‐counting of participants. No study groups were combined for the current review. </p> </section> <section id="CD005582-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We analysed data on an intention‐to‐treat basis, so that all participants with available data would be included in the analysis in the group to which they were allocated, regardless of whether they received the allocated intervention. If, in the original reports, participants were not analysed in the group to which they were randomised, and there was sufficient information in the trial report, we attempted to restore them to the correct group. We obtained missing data from the study authors whenever possible. </p> </section> <section id="CD005582-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity among trials using the Chi<sup>2</sup> test with a 10% level of statistical significance (P &lt; 0.1), and the I<sup>2</sup> statistic, along with a visual inspection of the forest plots. We followed the recommendations for the heterogeneity threshold outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005582-bbs2-0065" title="HigginsJPT , LassersonT , ThomasJ , FlemyngE , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews (MECIR). Cochrane: London, Version August 2023. Available from community.cochrane.org/mecir-manual.">Higgins 2023a</a>). </p> <p> <ol id="CD005582-list-0003"> <li> <p>0% to 40% might not be important;</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100% indicates considerable heterogeneity.</p> </li> </ol> </p> <p>If we identified substantial heterogeneity, we reported it and explored possible causes by prespecified subgroup analysis. </p> </section> <section id="CD005582-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>There were insufficient studies to use a funnel plot to investigate the possibility of publication bias. If there are sufficient studies in future updates, we will assess publication bias, as described in our protocol. </p> </section> <section id="CD005582-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analyses only when this was meaningful, that is, if the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense. We originally used RevMan 5 to undertake a meta‐analysis of the studies that reported on the efficacy of corticosteroids for preventing PHN, and displayed the results as a forest plot (<a href="./references#CD005582-bbs2-0084" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Cochrane, 2020.">Review Manager 2020</a>). Had we included a sufficient number of similar studies, we planned to compare different types of steroid versus placebo or no treatment separately. If there were insufficient studies, we included any type of steroid versus placebo or no treatment in a single comparison. </p> <p>We used a fixed‐effect model for meta‐analysis unless we identified unexplained heterogeneity, in which case, we planned to use a random‐effects model analysis. For trials that were clinically heterogeneous or provided insufficient information for pooling, we undertook a descriptive analysis (<a href="./references#CD005582-bbs2-0066" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.">Higgins 2023b</a>). </p> </section> <section id="CD005582-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Had there had been sufficient studies (at least 10 studies) for meaningful comparison of subgroups, we planned to use a formal statistical test in Review Manager to compare them. We planned to undertake the following subgroup analyses for the primary outcome. </p> <p> <ol id="CD005582-list-0004"> <li> <p>Treatment started sooner (24 hours or less after onset) or later (24 hours to 72 hours after onset; and more than 72 hours after onset) after the onset of herpes zoster </p> </li> <li> <p>Younger (up to 49 years old) and older (50 years old or more) participants</p> </li> <li> <p>Type of corticosteroid used (prednisolone or triamcinolone)</p> </li> </ol> </p> </section> <section id="CD005582-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out a sensitivity analysis on the basis of risk of bias, by repeating the analysis after omitting the trials that had a high or unclear risk of bias in some domains. </p> </section> <section id="CD005582-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We included a summary of findings table to illustrate the findings of the review and our assessment of the certainty of the evidence for the key outcomes: </p> <p> <ol id="CD005582-list-0005"> <li> <p>presence of PHN six months after the onset of the acute herpetic rash;</p> </li> <li> <p>serious adverse events;</p> </li> <li> <p>non‐serious adverse events.</p> </li> </ol> </p> <p>We graded the certainty of the evidence for these outcomes across the included RCTs as high, moderate, low, or very low, based on the GRADE criteria. We started at high for RCTs. Reasons for downgrading were: study limitations (risk of bias), inconsistency, imprecision, indirectness, and publication bias. We downgraded the certainty of evidence for each outcome once if a grade criterion was present to a serious degree and twice if very serious (<a href="./references#CD005582-bbs2-0054" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. [PMID: 15205295]">Atkins 2004</a>; <a href="./references#CD005582-bbs2-0090" title="SchünemannHJ , HigginsJPT , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.">Schünemann 2023</a>; <a href="./references#CD005582-bbs2-0092" title="SkoetzN , GoldkuhleM , vanDalenEC , AklEA , TrivellaM , MustafaRA , et al. GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles. Journal of Clinical Epidemiology2020;118:124-31. [PMID: 31711910]">Skoetz 2020</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005582-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005582-sec-0039"></div> <section id="CD005582-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD005582-sec-0041"> <h4 class="title">Results of the search</h4> <p>We retrieved 2068 records from the comprehensive literature search, and screened 1082 records after removal of duplicates. We assessed the titles and abstracts of 1082 records, excluding 1030 records. We identified a total of 52 potentially eligible records, excluded 46 reports after full‐text screening. Five trials (reported in five references) fulfilled our inclusion criteria; we identified one record as a study awaiting classification. We identified no new studies for inclusion in this update. A flow chart illustrating study selection is shown in <a href="#CD005582-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD005582-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD005582-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD005582-sec-0042"> <h4 class="title">Included studies</h4> <p>We included five trials with a total of 787 participants in this updated review (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). All included trials were randomised, double‐blind, placebo‐controlled, parallel‐group studies. Two were performed in a single centre; <a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a> was conducted in Denmark; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> was conducted in a Miami dermatology inpatient service. The others were performed in multiple centres; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a> was conducted in Aarhus and Copenhagen, Denmark; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a> was conducted in 15 university hospitals or affiliated clinics in the USA; and <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a> was conducted in four centres in the United Kingdom. </p> <section id="CD005582-sec-0043"> <h5 class="title">Participants</h5> <p>Four trials reported a range of ages from 16 to 91 years old (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>). Four trials stated the gender distribution (male 307, female 427), and mean age of participants (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). All five trials defined explicit inclusion criteria. One trial included participants with early, severely painful zoster (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>); the other four trials included participants with herpes or pain of different grades of severity. </p> <p>One trial included participants who were at least 60 years old, with onset of herpes zoster less than 96 hours before admission (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>). One trial included immunocompetent adults older than 50 years, who fell ill less than 72 hours before study enrolment (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>). One trial included adults who fell ill less than 72 hours before study enrolment (<a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). </p> <p>All five included trials also defined explicit exclusion criteria. They excluded participants with peptic ulcer, psychosis, malignant disease, hypertension, diabetes, cardiac insufficiency, adrenocortical disease, tuberculosis, lymphomas, leukaemias, bacterial infections, pregnancy, or those who were on corticosteroid treatment. The time from onset to start of treatment was zero to seven days in four included trials (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>); one trial only stated that the mean time was five days, and we were unable to obtain more details. </p> </section> <section id="CD005582-sec-0044"> <h5 class="title">Interventions</h5> <p>The treatment regimens varied between studies (see <a href="./references#CD005582-sec-0101" title="">Characteristics of included studies</a>). </p> <p>Two trials compared corticosteroids with placebo (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>). Three trials used aciclovir in combination with corticosteroids versus aciclovir in combination with placebo (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). One trial used oral triamcinolone (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>), four trials used oral prednisone (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>), and one trial administered adrenocorticotropic hormone (ACTH) intramuscularly (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>). All trials followed the participants for at least six months or until the PHN ended, or the participant no longer returned. One trial monitored all participants for three years (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>). </p> </section> <section id="CD005582-sec-0045"> <h5 class="title">Outcomes measured</h5> <p>Four trials reported the duration of PHN or presence of PHN at six months after the onset of the acute herpetic rash (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). Two trials did not provide separate information on the number of participants with PHN at six months and therefore, were not included in the meta‐analysis (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). All five included trials did not report, as a separate outcome, pain severity measured by a validated visual analogue scale or numerical descriptive scale after 3, 6, and 12 months, or the quality of life measured with the SF‐36 after six months. All five included trials reported adverse events during treatment or within two weeks after stopping treatment. Adverse events were categorised as serious or not serious. </p> </section> </section> <section id="CD005582-sec-0046"> <h4 class="title">Excluded studies</h4> <p>We excluded 46 trials (see <a href="./references#CD005582-sec-0102" title="">Characteristics of excluded studies</a>). The main reasons for exclusion were as follows: </p> <p> <ol id="CD005582-list-0006"> <li> <p>Study design: after contacting the study authors, 20 studies were not RCTs (<a href="./references#CD005582-bbs2-0006" title="AgarwalS , MalhotraYK , KallaS , KhullarR , KhareAK . Comparative efficacy of phenytoin, steroid and carbamazepine in herpes zoster and post herpetic neuralgia. Indian Journal of Dermatology, Venerology and Leprology1991;57:279-83. ">Agarwal 1991</a>; <a href="./references#CD005582-bbs2-0007" title="BruscoJE , JaimovichCB , BacchiocchiMF . Herpes zoster, study of 96 patients: postherpetic neuralgia and corticoids [Herpes zoster, estudio de 96 pacientes: neuralgia postherpética y corticoides]. Archivos Argentinos de Dermatología1993;43(3):175-83. ">Brusco 1993</a>; <a href="./references#CD005582-bbs2-0009" title="CuiSS , ChengXH . Evaluation of the effect of corticosteroids for the prevention of PHN in the elderly people. Journal of DaLian Medical University2002;24(2):116-7. ">Cui 2002</a>; <a href="./references#CD005582-bbs2-0013" title="HaoSZ . Clinical efficacy of acyclovir combined with prednisone for the treatment of 48 cases with herpes zoster in aged persons. Journal of JinZhou Medical College2002;23(5):57. ">Hao 2002</a>; <a href="./references#CD005582-bbs2-0014" title="HuangYZ . Clincial efficacy of acyclovir combined prednisone given by intravenous routes for the treatment of herpes zoster in middle-aged persons. International Medical &amp; Heath Guidance News2004;10(2-3):81-2. ">Huang 2004</a>; <a href="./references#CD005582-bbs2-0015" title="HuangZF , HuangYZ , MaDX . Combined treatment of famciclovir and compound betamethasone for herpes zoster in middle-aged and aged population [泛昔洛韦联合复方倍他米松注射液治疗中老年带状疱疹疗效观察]. Guangdong Medical Journal2010;31(13):1746-7. ">Huang 2010</a>; <a href="./references#CD005582-bbs2-0018" title="JiangCH . Short-term combined treatment with small dose of corticosteroids and acyclovir for herpes zoster. China Journal of Leprosy and Skin Disease2008;4:255. ">Jiang 2008</a>; <a href="./references#CD005582-bbs2-0020" title="LiYF . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Journal of Zhejiang Medicine. Science2000;22(7):441-2. ">Li 2000</a>; <a href="./references#CD005582-bbs2-0021" title="LiQH , ShiX , LiB . Clinical efficacy of acyclovir combined with prednisone for the treatment of herpes zoster in middle-aged persons. Chinese Journal of Dermatovenereology2002;16(3):2. ">Li 2002</a>; <a href="./references#CD005582-bbs2-0024" title="LinBS . Clinical efficacy of valacyclovir combined with low dosage of prednisone for the treatment of herpes zoster in aged persons. Southern China Journal of Dermato-Venereology2005;12(1):21-2. ">Lin 2005</a>; <a href="./references#CD005582-bbs2-0027" title="MaWY . Clincial observation of antiviral agents combined with dexamethasone for the treatment of herpes zoster. QingHai Medical Journal2000;30(10):44. ">Ma 2000</a>; <a href="./references#CD005582-bbs2-0028" title="MaJ , CaiAH , CaoMR . Glucocorticoid alleviates postherpetic neuralgia. Journal of China Clinical Medicine2002;9(5):578-9. ">Ma 2002</a>; <a href="./references#CD005582-bbs2-0034" title="ShiRY , LiuFZ . Acyclovir combined with prednisone for 24 patients with herpes zoster. Chinese Coummunity Doctors2008;12:37. ">Shi 2008</a>; <a href="./references#CD005582-bbs2-0035" title="SongKT . Combined treatment with interferon, acyclovir and steroid for patients with herpes zoster. Chinese Journal of Misdiagnosis2009;9(6):1344-5. ">Song 2009</a>; <a href="./references#CD005582-bbs2-0036" title="TangJC . Andrographolide combined with prednisone for the treatment of herpes zoster in middle-aged persons. JiLin Journal of Traditional Chinese Medicine2004;24(6):34. ">Tang 2004</a>; <a href="./references#CD005582-bbs2-0042" title="YangXM . Acyclovir combined with prednisone for herpes zoster. Chinese Journal of Clinical Rational Drug Use2010;3(6):31. ">Yang 2010</a>; <a href="./references#CD005582-bbs2-0045" title="ZengC . Corticosteroids for the treatment of postherpetic neuralgia [糖皮质激素治疗带状疱诊对防治后遗神经痛的疗效观察]. Zhong Guo Jian Kang Yue Kan (China Health Monthly)2011;30(5):49-50. ">Zeng 2011</a>; <a href="./references#CD005582-bbs2-0046" title="ZhangJM . A clinical comprehend of Virmax combined prednisone in the treatment of 30 cases with herpes zoster in aged persons. Journal of HanDan Medical College2003;16(2):115. ">Zhang 2003</a>; <a href="./references#CD005582-bbs2-0050" title="ZhouXY . Famciclovir combined with prednisone for the treatment of herpes zoster in aged persons. Journal of BaiQiuEn Medical College2000;26(6):647. ">Zhou 2000</a>; <a href="./references#CD005582-bbs2-0051" title="ZhouJ . Clinical effect investigation of herpes zoster with glucocorticosteroids and acyclovir in old patients. Journal of North Sichuan Medical College2008;23(3):255-6. ">Zhou 2008</a>); </p> </li> <li> <p>Concomitant treatments: in seven trials, participants received therapy that was mismatched in dosage, course of treatment, or routine treatment between corticosteroids and control groups (<a href="./references#CD005582-bbs2-0012" title="GuoQJ . Corticosteroids plus combined therapy for the treatment of 57 cases with herpes zoster. ShanDong Medical Journal2001;41(1):53. ">Guo 2001</a>; <a href="./references#CD005582-bbs2-0017" title="JiangMB , JiangJY , WangSJ . Clinical efficacy of ribaviron combined with dexamethasone for the treatment of 38 cases with herpes zoster in middle-aged persons. Theory and Practice of Chinese Medicine2005;15(2):163. ">Jiang 2005</a>; <a href="./references#CD005582-bbs2-0040" title="YangJ , HuangXY , HouJ . Control study of prednisone in prevention of senile postherpetic neuralgia. Journal of Clincial Dermatology2000;29(2):99-100. ">Yang 2000</a>; <a href="./references#CD005582-bbs2-0043" title="YingGW , HeQB , LiDQ , YuJB . Clinical observation of low dosage of corticosteroids for the prevention of PHN in elderly people. Chinese Journal of Geriatrics2004;23(8):579. ">Yin 2004</a>; <a href="./references#CD005582-bbs2-0044" title="YinGW , HeQB , LiDQ , YuJB . The observation of efficacy and safety of glucocorticoids for the treatment of herpes zoster. Chinese Journal of Practitioner2005;4(3):187. ">Yin 2005</a>; <a href="./references#CD005582-bbs2-0047" title="ZhangCM , WangFF , ZhuYM , RenY . Control study of prednisone in prevention of senile postherpetic neuralgia. Journal of ChengDe Medical College2004;21(3):199-200. ">Zhang 2004</a>; <a href="./references#CD005582-bbs2-0049" title="ZhengHY , HanJ . Clinical study of early combination treatment for patients with herpes zoster. Journal of Jingangshan Medical College2004;11(3):66. ">Zheng 2004</a>); </p> </li> <li> <p>Definition of PHN: four trials defined PHN as pain persisting at the site of shingles two weeks after the onset of the acute rash (<a href="./references#CD005582-bbs2-0008" title="ChangJF . Corticosteroids for the treatment of postherpetic neuralgia. Chinese Journal of Practical Medicine2004;4(9):830. ">Chang 2004</a>; <a href="./references#CD005582-bbs2-0025" title="LiuY , DunSH . Aciclovir combined with prednisone for the treatment of herpes zoster neuralgia in aged persons. Chinese Journal of Clinical Rehabilitation2003;7(11):1727. ">Liu 2003</a>; <a href="./references#CD005582-bbs2-0026" title="LiuYB . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster neuralgia in middle-aged persons. Journal of LiaoNing College of Traditional Chinese Medicine2005;7(3):251. ">Liu 2005</a>; <a href="./references#CD005582-bbs2-0041" title="YangJL , HuYY . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Practical Clinical Medicine2002;3(6):128. ">Yang 2002</a>), one trial defined PHN as pain persisting one week after total decrustation (<a href="./references#CD005582-bbs2-0022" title="LiaoJY , YanZQ , LiuGT . Acyclovir plus prednisone was applied to the treatment of senile herpes zoster. Clinical Journal of Military Surgeon2005;33(4):413-4. ">Liao 2005</a>); </p> </li> <li> <p>Short‐term follow‐up: five trials followed up for less than one month (<a href="./references#CD005582-bbs2-0008" title="ChangJF . Corticosteroids for the treatment of postherpetic neuralgia. Chinese Journal of Practical Medicine2004;4(9):830. ">Chang 2004</a>; <a href="./references#CD005582-bbs2-0022" title="LiaoJY , YanZQ , LiuGT . Acyclovir plus prednisone was applied to the treatment of senile herpes zoster. Clinical Journal of Military Surgeon2005;33(4):413-4. ">Liao 2005</a>; <a href="./references#CD005582-bbs2-0025" title="LiuY , DunSH . Aciclovir combined with prednisone for the treatment of herpes zoster neuralgia in aged persons. Chinese Journal of Clinical Rehabilitation2003;7(11):1727. ">Liu 2003</a>; <a href="./references#CD005582-bbs2-0026" title="LiuYB . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster neuralgia in middle-aged persons. Journal of LiaoNing College of Traditional Chinese Medicine2005;7(3):251. ">Liu 2005</a>; <a href="./references#CD005582-bbs2-0041" title="YangJL , HuYY . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Practical Clinical Medicine2002;3(6):128. ">Yang 2002</a>); </p> </li> <li> <p>Timing: four trials exceeded our seven days in treatment criterion (<a href="./references#CD005582-bbs2-0077" title="LinLZ . A combination oral therapy with prednisone and acyclovir in treatment of 34 cases with herpes zoster. Journal of Clinical Dermatology2002;31(1):30-1.">Lin 2002</a>; <a href="./references#CD005582-bbs2-0098" title="WangHQ . Clinical observation of valaciclovir combined with prednisone for the treatment of herpes zoster in middle-aged persons. Chinese Journal of Celiopathy2004;4(5):344-5.">Wang 2004</a>; <a href="./references#CD005582-bbs2-0101" title="XuYC . Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Journal of Clinical Dermatology1999;28(3):181.">Xu 1999</a>; <a href="./references#CD005582-bbs2-0103" title="ZhangJQ . Acyclovir combined with low dosage prednisone for the treatment of 30 cases with herpes zoster. Clinical Journal of Integrated Traditional and Western Medicine2005;5(3):44.">Zhang 2005</a>); </p> </li> <li> <p>Concomitant anaesthetics: in six trials, the intervention group was treated with corticosteroids plus anaesthetics (<a href="./references#CD005582-bbs2-0010" title="CuiJZ , ZhangXB , ZhuP , ZhaoZB , GengZS , ZhangYH , et al. Effect of repetitive intracutaneous injections with local anesthetics and steroids for acute thoracic herpes zoster and incidence of postherpetic neuralgia. Pain Medicine (Malden, Mass.)2017;18(8):1566-72. ">Cui 2017</a>; <a href="./references#CD005582-bbs2-0016" title="JiG , NiuJ , ShiY , HouL , LuY , XiongL . The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesthesia and Analgesia2009;109(5):1651-5. ">Ji 2009</a>; <a href="./references#CD005582-bbs2-0029" title="MakharitaMY , AmrYM , El-BayoumyY . Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician2012;15(6):467-74. ">Makharita 2012</a>; <a href="./references#CD005582-bbs2-0031" title="NiJ , WangX , TangY , YangL , ZengY , GuoY . Subcutaneous injection of triamcinolone and lidocaine to prevent postherpetic neuralgia. Pain Physician2017;20(5):397-403. ">Ni 2017</a>; <a href="./references#CD005582-bbs2-0032" title="PasqualucciA , PasqualucciV , GallaF , De AngelisV , MarzocchiV , ColussiR , et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiologica Scandinavica2000;44(8):910-8. ">Pasqualucci 2000</a>; <a href="./references#CD005582-bbs2-0037" title="vanWijckAJ , OpsteltenW , MoonsKG , vanEssenGA , StolkerRJ , KalkmanCJ , et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet2006;367(9506):219-24. [PMID: 16427490]">van Wijck 2006</a>); </p> </li> <li> <p>Administration route: other forms of administration of corticosteroids, such as epidural injection or intrathecal injection were used in five trials (<a href="./references#CD005582-bbs2-0011" title="DurejaGP , UsmaniH , KhanM , TahseenM , JamalA . Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes. Pain Physician2010;13(3):213-21. ">Dureja 2010</a>; <a href="./references#CD005582-bbs2-0032" title="PasqualucciA , PasqualucciV , GallaF , De AngelisV , MarzocchiV , ColussiR , et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiologica Scandinavica2000;44(8):910-8. ">Pasqualucci 2000</a>; <a href="./references#CD005582-bbs2-0033" title="RijsdijkM , Van WijckAJ , MeulenhoffPC , KavelaarsA , Van der TweelI , KalkmanCJ . No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. European Journal of Pain (London, England)2013;17(5):714-23. ">Rijsdijk 2013</a>; <a href="./references#CD005582-bbs2-0037" title="vanWijckAJ , OpsteltenW , MoonsKG , vanEssenGA , StolkerRJ , KalkmanCJ , et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet2006;367(9506):219-24. [PMID: 16427490]">van Wijck 2006</a>; <a href="./references#CD005582-bbs2-0030" title="NCT05208918. Combined application of pulsed RF and steroids to the DRG for PHN [Effectiveness and durability of combined application of pulsed radiofrequency and a steroid to the dorsal root ganglion for postherpetic neuralgia: a randomized controlled trial]. clinicaltrials.gov/ct2/show/NCT05208918 (first received 26 January 2016). ">NCT05208918</a>). </p> </li> </ol> </p> </section> <section id="CD005582-sec-0047"> <h4 class="title">Studies awaiting classification</h4> <p>The study currently awaiting classification did not clarify the exact course of disease from onset of herpes zoster to receipt of treatment (<a href="./references#CD005582-bbs2-0052" title="HuXY . Acyclovir combined with dexamethasone for the treatment of 45 cases with herpes zoster. World Journal of Infection2001;1:5-6. ">Hu 2001</a>). We contacted the study authors by mail but failed to receive any reply. Another article, which was classified as a study awaiting assessment in the first version of this Cochrane review, was a review of case reports and previous trials (<a href="./references#CD005582-bbs2-0075" title="LevinsonW , ShawJC . Treatment of herpes zoster with corticosteroids - fact or faith?Western Journal of Medicine1985;142(1):117-8.">Levinson 1985</a>). Although the authors of <a href="./references#CD005582-bbs2-0075" title="LevinsonW , ShawJC . Treatment of herpes zoster with corticosteroids - fact or faith?Western Journal of Medicine1985;142(1):117-8.">Levinson 1985</a> said they were investigating the feasibility of a multicentre trial in this field, we have not found any subsequent relevant trial reports, so we removed this article from studies awaiting assessment and included it under additional references. </p> </section> <section id="CD005582-sec-0048"> <h4 class="title">Ongoing studies</h4> <p>We found no ongoing studies that matched our eligibility criteria.</p> </section> </section> <section id="CD005582-sec-0049"> <h3 class="title">Risk of bias in included studies</h3> <p>For this update, according to the RoB 1 assessment (<a href="./references#CD005582-bbs2-0064" title="HigginsJPT , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>), we rated two trials at low risk of bias (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>), two at unclear risk of bias (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>), and one at high risk of bias (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>). See <a href="./references#CD005582-sec-0101" title="">Characteristics of included studies</a> and <a href="#CD005582-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD005582-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD005582-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD005582-sec-0050"> <h4 class="title">Allocation</h4> <section id="CD005582-sec-0051"> <h5 class="title">Random sequence generation</h5> <p>Three included trials reported the method of randomisation, and we judged them at low risk of bias for random sequence generation (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> used randomisation with a centralised code generated at a pharmacy. A supply of medication for each participant was assigned a different code number and distributed to the participants; the code of each participant was opened after a three‐year follow‐up. Both <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a> and <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a> used a computer‐generated randomisation code to randomly assign participants. </p> </section> <section id="CD005582-sec-0052"> <h5 class="title">Allocation concealment</h5> <p>We judged <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a> and <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> at low risk of bias for allocation concealment. In <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>, the randomisation code was stratified by study centre to assign participants in blocks of eight to either group, so that allocation concealment might be performed. <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> stated that "the code for each participant was opened after follow‐up for evaluation". Therefore, we rated this study at low risk of bias for allocation concealment. The method of allocation concealment in <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a> was unclear; therefore, we rated this domain at unclear risk of bias. </p> <p><a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a> and <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a> did not describe the method of randomisation, and it was not clear from the reports if there was adequate allocation concealment in either study; we judged them at unclear risk of bias for both selection bias domains. </p> </section> </section> <section id="CD005582-sec-0053"> <h4 class="title">Blinding</h4> <section id="CD005582-sec-0054"> <h5 class="title">Blinding of participants and personnel</h5> <p>We assessed the five included trials at low risk of performance bias. A placebo‐controlled design was used in all five trials to ensure that participants were unaware of their group allocation during the study. One of these trials used lactose as placebo (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>), another used calcium lactate (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>); the other three studies only stated that the placebo tablets were indistinguishable from the active medication, but did not describe their composition. </p> </section> <section id="CD005582-sec-0055"> <h5 class="title">Blinding of outcome assessors</h5> <p><a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>, reported to be double‐blind, did not describe whether outcome assessors were blinded but stated that the code of each participant was opened after follow‐up and evaluation, so we judged it at low risk of detection bias. The other four studies clearly stated that a double‐blind design was used, and outcome assessors were blinded to treatment assignment during the entire study period. We rated these studies at low risk of detection bias. </p> </section> </section> <section id="CD005582-sec-0056"> <h4 class="title">Incomplete outcome data</h4> <p>In <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>, six participants were withdrawn, but it was unclear whether the lack of compliance was due to inefficacy or side effects. The group to which those participants were first assigned was not specified, so bias from incomplete outcome data was possibly an issue in this study, and we judged it at high risk of bias. The other four studies all reported information about follow‐up and dropouts and described the reasons for dropping out clearly; we considered them at low risk. Only one study claimed that an intention‐to‐treat analysis was used (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>); the other four included studies did not state whether the analysis was by intention‐to‐treat, but there was sufficient information in three trial reports to restore them to the correct group and perform an intention‐to‐treat analysis in our review (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). </p> </section> <section id="CD005582-sec-0057"> <h4 class="title">Selective reporting</h4> <p>Since four of the included trials were designed primarily to assess the efficacy of corticosteroids during the acute phase of herpes zoster infection, and all reported negative results or marginal positive results for corticosteroids for preventing PHN, we considered the reporting bias introduced by the investigators to be small (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). For each included study, outcomes listed in the methods section were all reported. All the study's prespecified outcomes were reported as per protocol, so we judged all five included trials at low risk for selection bias. </p> </section> <section id="CD005582-sec-0058"> <h4 class="title">Other potential sources of bias</h4> <p>All trials considered baseline clinical features. In four trials, the baseline clinical features were similar between groups (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> did not describe baseline differences, but the authors reported no serious imbalances in baseline prognostic factors between groups. </p> <p>The included studies used different cutoff times to definite PHN. Although we clearly stated that PHN was pain persisting, or recurring, at the site of shingles at least one month after the onset of the acute rash, we did not restrict inclusion to studies using the same definition, so we would not introduce more missing data. </p> <p>We deemed all the included studies to be at low risk of other bias.</p> </section> </section> <section id="CD005582-sec-0059"> <h3 class="title" id="CD005582-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD005582-tbl-0001"><b>Summary of findings 1</b> Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</a> </p> <p>See <a href="./full#CD005582-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD005582-sec-0060"> <h4 class="title">Corticosteroids versus placebo or no treatment</h4> <section id="CD005582-sec-0061"> <h5 class="title">Primary outcome</h5> <section id="CD005582-sec-0062"> <h6 class="title">Presence of PHN six months after the onset of the acute herpetic rash</h6> <p>One trial, comparing triamcinolone with placebo, provided data on the presence of PHN six months after the onset of the acute herpetic rash (<a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>). Another trial comparing prednisolone plus routine treatment with placebo plus routine treatment provided data for our primary outcome (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>). The trial compared aciclovir plus corticosteroids with aciclovir plus placebo. We conducted a meta‐analysis combining relevant data from the above two trials, with a total of 114 participants, and we are uncertain about the effects of corticosteroids given acutely during zoster infection by oral administration in preventing postherpetic neuralgia (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.45 to 1.99, P = 0.89; 2 trials, 114 participants; very low‐certainty evidence; <a href="./references#CD005582-fig-0003" title="">Analysis 1.1</a>). We downgraded the certainty of the evidence by one level for serious risk of bias and two levels for very serious imprecision, due to a low number of events and participants and very wide CIs (<a href="./full#CD005582-tbl-0001">summary of findings Table 1</a>). </p> <p><a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a> used a cutoff time of six weeks for defining PHN, concluding that prednisone did not decrease the incidence of PHN. Since the numbers of participants with PHN six months after the rash onset could not be obtained, these data were not included in any meta‐analysis for effects of corticosteroids. </p> <p>Two other trials provided relevant data for this outcome, although not in a format which permitted inclusion in our meta‐analysis. In a trial with 201 participants, a Cox regression model analysis of the main effect of prednisone compared with no prednisone showed little or no difference in the time to cessation of zoster‐associated pain (ZAP; RR 1.26, 95% CI 0.91 to 1.75 (<a href="./references#CD005582-bbs2-0004" title="WhitleyRJ , WeissH , Gnann JW Jr, TyringS , MertzGJ , PappasPG , et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine1996;125(5):376-83. [PMID: 8702088]">Whitley 1996</a>)). From their Cox regression model, we used the generic inverse variance approach to calculate the main effect of prednisone compared with no prednisone and confirmed that there was no observed difference in the time to cessation of ZAP (RR 1.11, 95% CI 0.96 to 1.27; 1 trial, 201 participants; very low‐certainty evidence; <a href="./references#CD005582-fig-0004" title="">Analysis 1.2</a>). We downgraded the certainty of evidence by one level for unclear risk of bias and two levels for very serious imprecision due to few events and very wide CIs. In the trial with 400 participants, 349 of whom completed the study, the investigators did not detect differences between any of the treatment groups in the time to complete cessation of pain (<a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). The median time to cessation of pain was 147 and 120 days in the groups receiving 7‐day and 21‐day aciclovir without a corticosteroid, and 146 and 120 days in the two groups who received aciclovir with corticosteroids. Thus, the results of both these large trials agreed with the conclusion from the meta‐analysis of the two smaller trials that corticosteroids may not affect the presence of PHN after six months. </p> </section> </section> <section id="CD005582-sec-0063"> <h5 class="title">Secondary outcome measures</h5> <section id="CD005582-sec-0064"> <h6 class="title">Pain severity</h6> <p>Four trials evaluated pain intensity after using corticosteroids (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>; <a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>; <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a>). </p> <p>Three of them measured pain during the first month, using different evaluation methods, results of which we were unable to pool, even after attempting to convert the outcomes to dichotomous data. <a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a> (40 participants) graded pain from zero (no pain) to three (insufferable pain). There was no difference in mean pain score between the prednisone and placebo groups during the 21‐day treatment period; the score was lower in the ACTH group during the first four days of the trial (P = 0.02 to 0.03), but not after. <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a> (35 participants) reported that in participants older than 60 years, pain resolved spontaneously, but more rapidly with corticosteroids. <a href="./references#CD005582-bbs2-0005" title="WoodMJ , JohnsonRW , MckendrickMW , TaylorJ , MandalBK , CrooksJ . A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine1994;330(13):896-900. [PMID: 8114860]">Wood 1994a</a> (400 participants) observed a larger reduction in pain score in the corticosteroids group than in the non‐corticosteroids group on days 7 and 14 (P &lt; 0.01). </p> <p>Only one trial (18 participants) reported pain at six months: 18 participants reported pain, 15 of whom reported light pain, two reported moderate pain, and one reported severe pain. Of these, nine participants received prednisone and nine received placebo, but pain severity was not reported by intervention (<a href="./references#CD005582-bbs2-0003" title="EsmannV , GeilJP , KroonS , FoghH , PeterslundNA , Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet1987;2(8551):126-9. [PMID: 2885599]">Esmann 1987</a>). </p> <p>None of the studies reported pain at three or 12 months.</p> </section> <section id="CD005582-sec-0065"> <h6 class="title">Quality of life</h6> <p>None of the trials reported separate data on quality of life after six months, measured with the SF‐36. </p> </section> <section id="CD005582-sec-0066"> <h6 class="title">Adverse events during or within two weeks after stopping treatment</h6> <p>Adverse events were categorised as serious or not serious. Serious adverse events were those which were life‐threatening, required or prolonged hospitalisation, or caused death. Details for individual studies are in the <a href="./references#CD005582-sec-0101" title="">Characteristics of included studies</a>. </p> <section id="CD005582-sec-0067"> <p><b>Serious adverse events</b></p> <p>Two of the included trials explicitly recorded the absence of serious adverse effects attributable to the experimental treatment (<a href="./references#CD005582-bbs2-0001" title="ClemmensenOJ , AndersenKE . ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology1984;9(6):557-63. [PMID: 6388918]">Clemmensen 1984</a>; <a href="./references#CD005582-bbs2-0002" title="EaglsteinWH , KatzR , BrownJA . The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA1970;211(10):1681-3. [PMID: 4905733]">Eaglstein 1970</a>). </p> <p>The other three trials reported several serious adverse events, including acute cardiac insufficiency, myocardial infarction, pneumonia or bronchopneumonia, chest infection, haematemesis, and death from other, unspecified causes. </p> <p>The evidence is very uncertain about the effect of corticosteroids on serious adverse events (RR 1.65, 95% CI 0.51 to 5.29, P = 0.40; 5 trials, 755 participants; very low‐certainty evidence; <a href="./references#CD005582-fig-0005" title="">Analysis 1.3</a>). We downgraded the certainty of evidence by one level for serious risk of bias, and two levels for very serious imprecision due to a low number of events and very wide CIs. </p> </section> <section id="CD005582-sec-0068"> <p><b>Non‐serious adverse events</b></p> <p>All five trials reported details of non‐serious adverse events, including clinical manifestation or laboratory results, the number of participants experiencing each adverse event, and their distribution between groups. The most frequently reported non‐serious adverse events were gastrointestinal symptoms (such as dyspepsia, nausea, vomiting, and diarrhoea), dizziness, headache, sweats, rash, oedema, hyperglycaemia, and increased serum aspartate glutamyltransferase. Corticosteroids may have little or no effect on the overall incidence of non‐serious adverse events compared to placebo (RR 1.30, 95% CI 0.90 to 1.87, P = 0.16; 5 trials, 755 participants; low‐certainty evidence; <a href="./references#CD005582-fig-0006" title="">Analysis 1.4</a>). We downgraded the certainty of evidence by one level for serious risk of bias, and one level for serious imprecision due to very wide CIs. </p> </section> </section> </section> <section id="CD005582-sec-0069"> <h5 class="title">Subgroup analyses</h5> <p>We did not conduct any subgroup analyses due to the paucity of studies included in each analysis, and unavailable data. </p> </section> <section id="CD005582-sec-0070"> <h5 class="title">Sensitivity analyses</h5> <p>No significant heterogeneity (I<sup>2</sup> &gt; 50%) was present in any analysis. We were unable to undertake sensitivity analyses since most studies were at high or unclear risk in at least one domain. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005582-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005582-sec-0071"></div> <section id="CD005582-sec-0072"> <h3 class="title" id="CD005582-sec-0072">Summary of main results</h3> <p>Only five studies examining the prevention effects of corticosteroids in a total of 787 participants were suitable for inclusion in this review. This is a relatively small number in relation to the known variability in the outcome of postherpetic neuralgia (PHN). Based on a limited number of studies, we are uncertain about the effects of corticosteroids, given orally, during an acute zoster infection, on preventing postherpetic neuralgia. There was no difference in time to cessation of pain, measured in two large trials (550 participants). Four of the trials included in this review evaluated pain intensity changes after using corticosteroids, but used different pain evaluation methods, so we were unable to combine the data in our meta‐analysis. We did not identify any data on quality of life measured with the SF‐36 Health Survey after six months. The evidence regarding the occurrence of serious adverse events is very uncertain. Corticosteroids may result in little to no difference in the risk of non‐serious adverse events in people with acute herpes zoster. </p> <p>There was a lack of sufficient detail to permit extraction of all required data concerning subgroups of interest. In the absence of an observed effect in the primary outcome measures, and the fact that individual trials were too small to detect moderate effects, more extensive subgroup analysis would have been unreliable. We hope that publication of this review will encourage authors of future PHN prevention trials to collect and publish data that will allow the analysis of subgroups in subsequent systematic reviews. </p> </section> <section id="CD005582-sec-0073"> <h3 class="title" id="CD005582-sec-0073">Overall completeness and applicability of evidence</h3> <p>Most of the included trials addressed relevant endpoints for PHN and adverse effects, but data on the severity of pain measured by validated visual analogue or numerical descriptive scales and quality of life measured with the SF‐36 were limited. Therefore, there is no evidence to address the efficacy for these outcomes. </p> <p>No other forms of administration, such as epidural injection or intrathecal administration were included. Thus, the results of our review are limited to oral or intramuscular corticosteroids. </p> <p>The studies were mostly from Europe and the USA, and all the studies were over 30 years old; best practice in PHN prevention has changed over time. Some newer studies have reported that combined corticosteroids and anaesthetic can reduce the risk of PHN and duration of neuralgic pain in people with herpes zoster rash (<a href="./references#CD005582-bbs2-0069" title="KimHJ , AhnHS , LeeJY , ChoiSS , CheongYS , KwonK , et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean Journal of Pain2017;30(1):3-17. [PMID: 28119767]">Kim 2017</a>; <a href="./references#CD005582-bbs2-0070" title="KimJ , KimMK , ChoiGJ , ShinHY , KimBG , KangH . Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean Journal of Pain2021;34(4):509-33. [PMID: 34593669]">Kim 2021</a>; <a href="./references#CD005582-bbs2-0104" title="ZhangX , WangZ , XianY . Efficacy of local anaesthetic and steroid combination in prevention of post-herpetic neuralgia: a meta-analysis. Pakistan Journal of Medical Sciences2022;38(3Part-I):757-65. [PMID: 35480541]">Zhang 2022</a>). </p> </section> <section id="CD005582-sec-0074"> <h3 class="title" id="CD005582-sec-0074">Quality of the evidence</h3> <p>All included trials were randomised, double‐blind, placebo‐controlled parallel studies. We rated two trials at low risk of bias, because of their design and efforts to avoid selection, performance, detection, attrition, reporting, and other biases. We rated two trials as unclear, since they had an unclear risk of bias for one or more key domains, commonly for allocation concealment and random sequence generation. We rated one trial at high risk of bias, mainly due to its incomplete outcome data. </p> <p>We rated the certainty of evidence for the primary outcome as very low, due to serious risk of bias and very serious imprecision. Hence, we were unable to draw conclusions on the efficacy of corticosteroids for preventing PHN. </p> </section> <section id="CD005582-sec-0075"> <h3 class="title" id="CD005582-sec-0075">Potential biases in the review process</h3> <p>We attempted to comprehensively search the pertinent literature, including published and unpublished studies, without any language restrictions, and contacted the investigators to acquire additional information, as required. However, we were unable to obtain further data from the trial authors or pharmaceutical companies, and it remains possible that important studies were missed. To reduce the risk of attrition bias, we used an intention‐to‐treat approach for the meta‐analyses. In addition, the small number of studies did not permit any of our planned subgroup and sensitivity analyses, and questions around participant selection and optimal treatment schedule remain. </p> </section> <section id="CD005582-sec-0076"> <h3 class="title" id="CD005582-sec-0076">Agreements and disagreements with other studies or reviews</h3> <p>Because we assessed the evidence to be of low and very low certainty, we are uncertain whether corticosteroids given during an acute zoster infection have a clinical impact on the prevention of postherpetic neuralgia. </p> <p>There have been a number of reviews and meta‐analyses completed for the treatment or prevention of PHN, largely based on the same trials that we included in our review, but their results were inconsistent. <a href="./references#CD005582-bbs2-0082" title="NaldiL , ZucchiA , BreviA , Cavalierid'OroL , CainelliT . Corticosteroids and post-herpetic neuralgia. Lancet1990;336(8720):947. [PMID: 1976963]">Naldi 1990</a> published an overview of four clinical trials with corticosteroids versus placebo or carbamazepine for preventing PHN. They found that corticosteroids had no effect on the development of PHN. However, a meta‐analysis of the same four trials undertaken in <a href="./references#CD005582-bbs2-0078" title="LyckaBA . Postherpetic neuralgia and systemic corticosteroid therapy. Efficacy and safety. International Journal of Dermatology1990;29(7):523-7. [PMID: 2146232]">Lycka 1990</a> showed a significant decrease in the prevalence of PHN at six and 12 months amongs corticosteroids recipients. Recently, <a href="./references#CD005582-bbs2-0070" title="KimJ , KimMK , ChoiGJ , ShinHY , KimBG , KangH . Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean Journal of Pain2021;34(4):509-33. [PMID: 34593669]">Kim 2021</a> undertook a comprehensive review and meta‐analysis to investigate the effects of various strategies used to prevent PHN; the results showed no benefit of corticosteroids for reducing the incidence of PHN. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005582-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD005582-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005582-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD005582-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005582-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Corticosteroids versus placebo, Outcome 1: The presence of PHN six months after the onset of acute herpetic rash" data-id="CD005582-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Corticosteroids versus placebo, Outcome 1: The presence of PHN six months after the onset of acute herpetic rash </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#CD005582-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005582-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Corticosteroids versus placebo, Outcome 2: The main effect of prednisone compared with no prednisone on six months evaluation of pain (generic inverse variance)" data-id="CD005582-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Corticosteroids versus placebo, Outcome 2: The main effect of prednisone compared with no prednisone on six months evaluation of pain (generic inverse variance) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#CD005582-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005582-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Corticosteroids versus placebo, Outcome 3: Serious adverse events" data-id="CD005582-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Corticosteroids versus placebo, Outcome 3: Serious adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#CD005582-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005582-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/urn:x-wiley:14651858:media:CD005582:CD005582-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Corticosteroids versus placebo, Outcome 4: Non‐serious adverse events" data-id="CD005582-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_t/tCD005582-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Corticosteroids versus placebo, Outcome 4: Non‐serious adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#CD005582-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/media/CDSR/CD005582/image_n/nCD005582-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005582-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute herpes zoster (within 7 days of onset of rash)<br/><b>Settings:</b> hospitals and clinics<br/><b>Intervention:</b> corticosteroids </p> <p><b>Comparison:</b> placebo or routine treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo or routine treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corticosteroids</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Presence of PHN 6 months after the onset of acute herpetic rash</b><br/>Clinical manifestation<br/><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>193 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b><br/>(87 to 384) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.95</b> <br/>(0.45 to 1.99) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b><br/>Clinical manifestation and laboratory examination </p> <p><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>13 per 1000</b><br/>(3 to 42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.51 to 5.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b><br/>Clinical manifestation and laboratory examination </p> <p><i>Follow‐up: 6 to 23 months</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>113 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b><br/>(102 to 211) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b> <br/>(0.90 to 1.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>PHN:</b> postherpetic neuralgia; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level for serious risk of bias and 2 levels for very serious imprecision, due to the low number of events and participants and very wide CI.<br/><sup>b</sup>Downgraded 1 level for serious risk of bias and 2 levels for very serious imprecision, due to the low number of events and very wide CI.<br/><sup>c</sup>Downgraded 1 level for serious risk of bias and 1 level for serious imprecision, due to very wide CI. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Corticosteroids for acute herpes zoster to prevent postherpetic neuralgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/full#CD005582-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005582-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 The presence of PHN six months after the onset of acute herpetic rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.45, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 The main effect of prednisone compared with no prednisone on six months evaluation of pain (generic inverse variance) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>RR Ratios (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.51, 5.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.90, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005582.pub5/references#CD005582-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005582.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005582-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005582-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005582-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005582-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD005582-note-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD005582-note-0014">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ko#CD005582-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD005582-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD005582-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="ro#CD005582-note-0016">Română</a> </li> <li class="section-language"> <a class="" href="th#CD005582-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005582-note-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005582-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005582\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005582\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005582\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005582\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005582\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005582.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005582.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005582.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005582.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005582.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728211551"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005582.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728211555"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005582.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebef4ab05f46e',t:'MTc0MDcyODIxMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 